Inhibitors of the FcRn:IgG protein-protein interaction

AAPS Journal

Volumn 11, Issue 3, 2009, Pages 432-434

  Low, Susan C ^a   Mezo, Adam R ^a  

^a Syntonix Pharmaceuticals Inc   (United States)

Author keywords

Engineered Fc; FcRn; IgG; Inhibitors; Monoclonal antibody; Peptide

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4C9; PEPTIDE ANTIBODY; SERYLTYROSYLASPARTIC ACID 1436; TRASTUZUMAB; UNCLASSIFIED DRUG;

BINDING AFFINITY; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG TARGETING; LIGAND BINDING; MAXIMUM PLASMA CONCENTRATION; MYASTHENIA GRAVIS; NONHUMAN; PROTEIN PROTEIN INTERACTION; RECEPTOR BLOCKING; SHORT SURVEY;

ANIMALS; ANTIBODIES; HALF-LIFE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN G; PROTEIN BINDING; PROTEIN ENGINEERING; RECEPTORS, FC;

EID: 73349108766     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-009-9120-5     Document Type: Short Survey

References (30)

1. FW Brambell WA Hemmings IG Morris 1964 A theoretical model of gamma-globulin catabolism Nature 203 1352 1354 14207307 10.1038/2031352a0 1:STN:280:DyaF2M%2FhtFKruw%3D%3D
2. JL Fahey AG Robinson 1963 Factors controlling serum gamma-globulin concentration J Exp Med. 118 845 868 14087625 10.1084/jem.118.5.845 1:CAS:528:DyaF2cXnslKnsg%3D%3D
3. NE Simister KE Mostov 1989 An Fc receptor structurally related to MHC class I antigens Nature 337 184 187 2911353 10.1038/337184a0 1:CAS:528:DyaL1MXltFegtr8%3D (Pubitemid 19025381)
4. DC Roopenian S Akilesh 2007 FcRn: the neonatal Fc receptor comes of age Nat Rev Immunol. 7 715 725 17703228 10.1038/nri2155 1:CAS:528: DC%2BD2sXpsV2qtbw%3D (Pubitemid 47327396)
5. V Ghetie ES Ward 2000 Multiple roles for the major histocompatibility complex class I-related receptor FcRn Annu Rev Immunol. 18 739 766 10837074 10.1146/annurev.immunol.18.1.739 1:CAS:528:DC%2BD3cXjs1Gmtrk%3D (Pubitemid 30365396)
6. DC Roopenian GJ Christianson TJ Sproule AC Brown S Akilesh N Jung S Petkova L Avanessian EY Choi DJ Shaffer PA Eden CL Anderson 2003 The MHC class I-like receptor controls perinatal IgG transport, IgG homeostasis, and the fate of IgG-Fc-coupled drugs J Immunol. 170 3528 3533 12646614 1:CAS:528: DC%2BD3sXitFKltr0%3D
7. V Ghetie JG Hubbard JK Kim MF Tsen Y Lee ES Ward 1996 Abnormally short serum half-lives of IgG in beta-2-microglobulin deficient mice Eur J Immunol 26 690 696 8605939 10.1002/eji.1830260327 1:CAS:528:DyaK28XhvVGntLg%3D (Pubitemid 26091401)
8. EJ Israel DF Wilsker KC Hayes D Schoenfeld NE Simister 1996 Increaesd clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn Immunolgy 89 573 578 10.1046/j.1365-2567.1996.d01-775.x 1:CAS:528:DyaK2sXlsV2m
9. RP Junghans CL Anderson 1996 The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor Proc Natl Acad Sci U S A 93 5512 5516 8643606 10.1073/pnas.93.11.5512 1:CAS:528:DyaK28Xjt1Ojsb8%3D (Pubitemid 26159481)
10. JK Kim MF Tsen V Ghetie ES Ward 1994 Localization of the site of the murine IgG1 molecule that is involved in the binding to the murine intestinal Fc receptor Eur J Immunol. 24 2429 2434 7925571 10.1002/eji.1830241025 1:CAS:528:DyaK2cXmsFegsb4%3D (Pubitemid 24303088)
11. S Popov JG Hubbard J Kim B Ober V Ghetie ES Ward 1996 The stiochiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn Mol Immunol. 33 521 530 8700168 10.1016/0161-5890(96) 00004-1 1:CAS:528:DyaK28Xks1Shs7k%3D (Pubitemid 26228389)
12. Z Liu DC Roopenian X Zhou GJ Christianson LA Diaz DD Sedmak CL Anderson 1997 Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid J Exp Med. 186 777 783 9271593 10.1084/jem.186.5.777 1:CAS:528:DyaK2sXlvVeitLs%3D (Pubitemid 27381542)
13. Z Yu VA Lennon 1999 Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases N Engl J Med. 340 227 228 9895405 10.1056/NEJM199901213400311 1:STN:280:DyaK1M7gtFyksA%3D%3D (Pubitemid 29063222)
14. S Akilesh S Petkova TJ Sproule DJ Shaffer GJ Christianson DC Roopinean 2004 The MHC class I-like Fc receptor promotes humorally mediated autoimmune diseases J Clin Invest. 113 1328 1333 15124024 1:CAS:528:DC%2BD2cXjvVOqs7o%3D
15. N Li M Zhao J Hilario-Vargas P Prisayanh S Warren LA Diaz DC Roopenian Z Liu 2005 Complete FcRn-dependence for intravenous Ig therapy in autoimmune skin blistering diseases J Clin Invest. 115 3440 3450 16284651 10.1172/JCI24394 1:CAS:528:DC%2BD2MXhtlSqtLrI (Pubitemid 43121832)
16. A Sesarman AG Sitaru F Olaru D Zilliken CJ Sitaru 2008 Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita Mol Med. 86 951 959 10.1007/s00109-008-0366-7 1:CAS:528:DC%2BD1cXptVCntbs%3D
17. WK Bleeker JL Teeling CE Hack 2001 Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect Blood 98 3136 3142 11698302 10.1182/blood.V98.10.3136 1:CAS:528:DC%2BD3MXosFyntLo%3D
18. RJ Hansen JP Balthasar 2002 Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia Blood 100 2087 2093 12200371 1:CAS:528:DC%2BD38Xnt1yhs7g%3D
19. M Raghavan MY Chen LN Gastinel PJ Bjorkman 1994 Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand Immunity 1 303 315 7889418 10.1016/1074-7613(94)90082-5 1:CAS:528:DyaK2cXmvFyksbg%3D (Pubitemid 2114863)
20. L Liu AM Garcia H Santoro Y Zhang K McDonnell J Dumont AJ Bitonti 2007 Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade J Immunol. 178 5390 5398 17404325 1:CAS:528:DC%2BD2sXjslWjtbY%3D
21. MW Nicolle 2002 Myathenia gravis Neurologist 8 2 21 12803656 10.1097/00127893-200201000-00002
22. KE Getman JP Balthasar 2005 Pharmacokinetic effects of 4C9, anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of autoimmune and alloimmune conditions J Pharm Sci. 94 718 729 15682382 10.1002/jps.20297 1:CAS:528:DC%2BD2MXjtFCjtbY%3D (Pubitemid 40577305)
23. TA Waldmann W Strober 1969 Metabolism of immunoglobulins Prog Allergy 13 1 110 4186070 1:CAS:528:DyaF1MXlt1WlurY%3D
24. SB Petkova S Akilesh TJ Sproule GJ Christianson HA Khabbaz AC Brown LG Presta YG Meng DC Roopenian 2006 Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease Int Immunol. 18 1759 1769 17077181 10.1093/intimm/dxl110 1:CAS:528:DC%2BD28Xht1KksbnK (Pubitemid 44884038)
25. RL Shields AK Namenuk K Hong YG Meng J Rae J Briggs D Xie J Lai A Stadlen B Li JA Fox LG Presta 2001 High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R J Biol Chem. 276 6591 6604 11096108 10.1074/jbc.M009483200 1:CAS:528:DC%2BD3MXhslShurs%3D
26. SB Petkova KN Konstantinov SJ Sproule BL Lyons MA Awwami DC Roopenian 2006 Human antibodies induce arthritis in mice deficient in the low affinity inhibitory IgG receptor Fc gamma RIIB J Exp Med 203 275280 10.1084/jem.20051951 (Pubitemid 43290836)
27. C Vaccaro J Zhou R Ober ES Ward 2005 Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels Nat Biotechnol. 23 1283 1288 16186811 10.1038/nbt1143 1:CAS:528:DC%2BD2MXhtVOhu7nM (Pubitemid 41486856)
28. C Vaccaro R Bawdon S Wanjie RJ Ober ES Ward 2006 Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies Proc Nat Acad Sci U S A 103 18709 18714 10.1073/pnas.0606304103 1:CAS:528:DC%2BD28Xhtlaht73N (Pubitemid 44913475)
29. AR Mezo KA McDonnell CA Hehir SC Low VJ Palombella JM Stattel GD Kamphaus C Fraley Y Zhang JD Dumont AJ Bitonti 2008 Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn Proc Nat Acad Sci U S A 105 2337 2342 10.1073/pnas.0708960105 1:CAS:528:DC%2BD1cXis1Kiu70%3D
30. AR Mezo KA McDonnell A Castro C Fraley 2008 Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction Bioorg Med Chem. 16 6394 6405 18501614 10.1016/j.bmc.2008.05.004 1:CAS:528:DC%2BD1cXntlagtLk%3D (Pubitemid 351783417)